<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Distinguishing findings in the evaluation of suspected transfusion reactions</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Distinguishing findings in the evaluation of suspected transfusion reactions</h1>
<div class="graphic"><div class="figure"><div class="ttl">Distinguishing findings in the evaluation of suspected transfusion reactions</div><div class="cntnt"><table cellspacing="0"><colgroup span="5" width="20%"></colgroup> <tbody> <tr class="divider_bottom"> <td class="subtitle1">Reaction</td> <td class="subtitle1">Typical time course<sup>*</sup></td> <td class="subtitle1">Clinical findings</td> <td class="subtitle1">Laboratory findings</td> <td class="subtitle1">Implicated products</td> </tr> <tr class="divider_bottom"> <td>Acute hemolytic transfusion reaction</td> <td>During transfusion or within 24 hours of transfusion completion</td> <td>Fever, chills, hypotension, back pain, DIC</td> <td>Hemoglobinemia, hemoglobinuria, positive direct antiglobulin (Coombs) test (may be negative if all cells have hemolyzed), findings of DIC (prolonged PT, prolonged aPTT, low fibrinogen, thrombocytopenia)</td> <td> <p>RBCs, plasma (much less common), rarely platelets</p> Incompatible blood product (typically ABO incompatible due to clerical error)</td> </tr> <tr class="divider_bottom"> <td>Anaphylactic transfusion reaction</td> <td>During transfusion or within 4 hours of transfusion completion</td> <td>Hypotension, angioedema, wheezing, respiratory distress</td> <td>Hypoxemia, IgA deficiency, anti-IgA</td> <td>RBCs, platelets, plasma products</td> </tr> <tr class="divider_bottom"> <td>Transfusion-related acute lung injury (TRALI)</td> <td>During transfusion or within 6 hours of transfusion completion</td> <td>Respiratory distress, hypotension</td> <td>Abnormal chest radiography, hypoxemia, transient leukopenia, anti-neutrophil or anti-HLA antibodies (if tested)</td> <td>RBCs, platelets, plasma products</td> </tr> <tr class="divider_bottom"> <td>Transfusion-associated circulatory overload (TACO)</td> <td>During transfusion or within 12 hours of transfusion completion</td> <td>Respiratory distress, rales</td> <td>Abnormal chest radiography, hypoxemia, increased BNP or NT-proBNP</td> <td>RBCs, platelets, plasma products, and other fluids</td> </tr> <tr class="divider_bottom"> <td>Sepsis/bacterial infection</td> <td>During transfusion or within 72 hours of transfusion completion</td> <td>Fever, chills, hypotension, DIC</td> <td>Bacteremia, leukocytosis, findings of DIC</td> <td> <p>Platelets most commonly implicated, but can be any product</p> Product may show bacterial contamination</td> </tr> <tr class="divider_bottom"> <td>Febrile non-hemolytic transfusion reaction</td> <td>During transfusion or within 4 hours of transfusion completion</td> <td>Fever</td> <td>None</td> <td>All blood products, but plasma is much rarer</td> </tr> <tr> <td>Allergic transfusion reaction</td> <td>During transfusion or within 4 hours of transfusion completion</td> <td>Hives, urticaria</td> <td>None unless specific investigation is made</td> <td>All blood products</td> </tr> </tbody></table></div><div class="graphic_lgnd">The table includes some common findings but is not comprehensive and does not substitute for clinical judgment in the patient evaluation. Not all of the findings listed under each reaction will be present in every case. Refer to UpToDate topics on transfusion reactions for details of evaluation, diagnosis, and management.</div><div class="graphic_footnotes"><p>aPTT: activated partial thromboplastin time; BNP: brain natriuretic peptide; DIC: disseminated intravascular coagulation; HLA: human leukocyte antigens; Ig: immunoglobulin; NT-proBNP: N-terminal BNP; PT: prothrombin time; RBCs: red blood cells.</p>
* Except for sepsis/bacterial infection, all typical time course criteria are from the Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network Biovigilance Component. Septic transfusion reactions generally occur immediately after initiating the transfusion but may take time to develop depending on the size of the bacterial inoculum.</div><div class="graphic_reference">Adapted from: Sazama K, DeChristopher PJ, Dodd R, et al. Practice parameter for the recognition, management, and prevention of adverse consequences of blood transfusion. College of American Pathologists. Arch Pathol Lab Med 2000; 124:61.</div><div id="graphicVersion">Graphic 94399 Version 8.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
